Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 27.68B |
| Enterprise value | 33.97B |
| Trailing P/E | 23.90 |
| Forward P/E | 12.42 |
| PEG ratio (5-yr expected) | 6.24 |
| Price/sales (ttm) | 2.82 |
| Price/book (mrq) | 1.87 |
| Enterprise value/revenue | 3.45 |
| Enterprise value/EBITDA | 16.67 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.01 |
| 52-week change 3 | -35.20% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 319.76 |
| 52-week low 3 | 189.52 |
| 50-day moving average 3 | 217.09 |
| 200-day moving average 3 | 245.76 |
Share statistics
| Avg vol (3-month) 3 | 1.17M |
| Avg vol (10-day) 3 | 1.07M |
| Shares outstanding 5 | 145.36M |
| Implied shares outstanding 6 | 145.36M |
| Float 8 | 144.82M |
| % held by insiders 1 | 0.69% |
| % held by institutions 1 | 92.97% |
| Shares short (28 Mar 2024) 4 | 3.55M |
| Short ratio (28 Mar 2024) 4 | 2.66 |
| Short % of float (28 Mar 2024) 4 | 2.76% |
| Short % of shares outstanding (28 Mar 2024) 4 | 2.44% |
| Shares short (prior month 29 Feb 2024) 4 | 2.8M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 18 Jan 2001 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 11.81% |
| Operating margin (ttm) | 19.32% |
Management effectiveness
| Return on assets (ttm) | 4.58% |
| Return on equity (ttm) | 8.24% |
Income statement
| Revenue (ttm) | 9.84B |
| Revenue per share (ttm) | 67.97 |
| Quarterly revenue growth (yoy) | -6.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 2.38B |
| Net income avi to common (ttm) | 1.16B |
| Diluted EPS (ttm) | 7.96 |
| Quarterly earnings growth (yoy) | -54.60% |
Balance sheet
| Total cash (mrq) | 1.05B |
| Total cash per share (mrq) | 7.22 |
| Total debt (mrq) | 7.43B |
| Total debt/equity (mrq) | 50.20% |
| Current ratio (mrq) | 2.00 |
| Book value per share (mrq) | 102.14 |
Cash flow statement
| Operating cash flow (ttm) | 1.55B |
| Levered free cash flow (ttm) | 971.06M |
© 2024 Yahoo. All rights reserved.